{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:25:32Z","timestamp":1791321932724,"version":"4.3.1"},"reference-count":36,"publisher":"BMJ","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Epidemiol Community Health"],"published-print":{"date-parts":[[1998,12]]},"abstract":"<jats:p>STUDY OBJECTIVE: To assess age specific incidence and mortality of stroke, acute myocardial infarction (AMI), and idiopathic venous thromboembolism (VTE) associated with use of modern low dose combined oral contraceptives (OCs) and the interaction with smoking. DESIGN: Hospital-based case-control study. SETTING: Hospitals in Oxford region in the United Kingdom, which covered a defined population, during the period 1989-1993. METHODS: Relative risk estimates from the WHO Collaborative Study and observed incidence rates from the Oxford region were used to estimate age specific incidence of each disease among women without cardiovascular risk factors and model total cardiovascular incidence and mortality. RESULTS: Among women who did not use OCs, smoke nor had any other cardiovascular risk factors, total incidence of stroke and AMI were less than 2 events per 100,000 woman years in those aged 20-24 years and rose exponentially with age to 8 events per 100,000 among women aged 40-44 years. Incidence of idiopathic VTE among women who did not use OCs rose linearly with age (from 3.3 per 100,000 at ages 20-24 years to 5.8 per 100,000 at ages 40-44 years). The increased risk of idiopathic VTE associated with OC use among non-smokers constituted over 90% of all cardiovascular events for women aged 20-24 years and more than 60% in those aged 40-44 years. Fatal cardiovascular events were dominated by haemorrhagic stroke and AMI, and among OC users who smoked these two diseases accounted for 80% of cardiovascular deaths among women aged 20-24 years, rising to 97% among those aged 40-44 years. Cardiovascular mortality associated with smoking was greater than that associated with OC use at all ages. Attributable risk associated with OC use was 1 death per 370,000 users annually among women aged 20-24 years, 1 per 170,000 at ages 30-34 years, and 1 per 37,000 at ages 40-44 years. Among smokers, the cardiovascular mortality attributable to OC use was estimated to be about 1 per 100,000 users annually among women aged less than 35 years, and about 1 per 10,000 users annually among those above the age of 35 years. CONCLUSION: The incidence of fatal cardiovascular events among women aged less than 35 years is low. The VTE risk associated with OC use is the largest contributor to OC induced adverse effects. The potentially avoidable excess VTE risk associated with the newer progestogens desogestrel and gestodene would account for a substantial proportion of total cardiovascular morbidity in this age group. For women over age 35 years the absolute risks associated with OC use and smoking are greater because of the steeply rising incidence of arterial diseases. The combination of smoking and OC use among such women is associated with particularly increased risks. Any potential reduction in AMI or stroke risk with use of third generation OCs would be a more important consideration among older compared with younger women, particularly if they smoke. However, the mortality associated with smoking is far greater than that associated with OC use (of any type) at all ages.<\/jats:p>","DOI":"10.1136\/jech.52.12.775","type":"journal-article","created":{"date-parts":[[2009,1,5]],"date-time":"2009-01-05T14:15:53Z","timestamp":1231164953000},"page":"775-785","source":"Crossref","is-referenced-by-count":68,"title":["Combined oral contraceptives, smoking, and cardiovascular risk."],"prefix":"10.1136","volume":"52","author":[{"given":"T M","family":"Farley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Meirik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C L","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N R","family":"Poulter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1998,12,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: Results of an international multicentre case-control study","volume":"346","year":"1995","unstructured":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: Results of an international multicentre case-control study. Lancet 1995;346:1575\u201382.","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. EVect of diVerent progestagens in low oestrogen oral contraceptives on venous thromboembolic disease","volume":"346","year":"1995","unstructured":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. EVect of diVerent progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995;346:1582\u20138.","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(95)12393-8","article-title":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Ischaemic stroke and combined oral contraceptives: Results of an international multicentre case-control study","volume":"348","year":"1996","unstructured":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Ischaemic stroke and combined oral contraceptives: Results of an international multicentre case-control study. Lancet 1996;348:498\u2013505.","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(95)12394-6","article-title":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: Results of an international, multicentre, case-control study","volume":"348","year":"1996","unstructured":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: Results of an international, multicentre, case-control study. Lancet 1996;348:505\u201310.","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0140-6736(97)02358-1","article-title":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Acute myocardial infarction and combined oral contraceptives: Results of an international multicentre case-control study","volume":"349","year":"1997","unstructured":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Acute myocardial infarction and combined oral contraceptives: Results of an international multicentre case-control study. Lancet 1997;349:1202\u20139.","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/jech.50.6.674","article-title":"Reliability of data from proxy respondents in an international casecontrol study of cardiovascular disease and oral contraceptives","volume":"50","author":"Poulter, N.R.; Chang, C.L.; Farley, T.M.M.","year":"1996","unstructured":"Poulter NR, Chang CL, Farley TMM, et al. Reliability of data from proxy respondents in an international casecontrol study of cardiovascular disease and oral contraceptives. J Epidemiol Community Health 1996;50:674\u201380.","journal-title":"J Epidemiol Community Health"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/0895-4356(95)00516-1","article-title":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. A multinational case-control study of cardiovascular disease and steroid hormone contraceptives. Description and validation of methods","volume":"48","year":"1995","unstructured":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. A multinational case-control study of cardiovascular disease and steroid hormone contraceptives. Description and validation of methods. J Clin Epidemiol 1995;48:1513\u201347.","journal-title":"J Clin Epidemiol"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/01.STR.26.3.361","article-title":"for the WHO MONICA project. Stroke incidence, case fatality, and mortality in the WHO MONICA project","volume":"26","author":"Thorvaldsen, P.; Asplund, K.; Kuulasmaa, K.","year":"1995","unstructured":"Thorvaldsen P, Asplund K, Kuulasmaa K, et al, for the WHO MONICA project. Stroke incidence, case fatality, and mortality in the WHO MONICA project. Stroke 1995; 26:361\u20137.","journal-title":"Stroke"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/01.CIR.90.1.583","article-title":"Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: Registration procedures, event rates and casefatality rates in 38 populations from 21 countries in four continents","volume":"90","author":"Project, W.H.O.M.O.N.I.C.A.","year":"1994","unstructured":"WHO MONICA Project. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: Registration procedures, event rates and casefatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583\u2013612.","journal-title":"Circulation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1056\/NEJM198109103051104","article-title":"Oral contraceptives and cardiovascular disease (part I)","volume":"305","author":"Stadel, B.V.","year":"1981","unstructured":"Stadel BV. Oral contraceptives and cardiovascular disease (part I). N Engl J Med 1981;305:612\u201318.","journal-title":"N Engl J Med"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0029-7844(96)00351-1","article-title":"Myocardial infarction in users of low-dose oral contraceptives","volume":"88","author":"Sidney, S.; Petitti, D.B.; Quesenberry, C.P.","year":"1996","unstructured":"Sidney S, Petitti DB, Quesenberry CP, et al. Myocardial infarction in users of low-dose oral contraceptives. Obstet Gynecol 1996;88:939\u201344.","journal-title":"Obstet Gynecol"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM199607043350102","article-title":"Stroke in users of low-dose oral contraceptives","volume":"335","author":"Petitti, D.B.; Sidney, S.; Bernstein, A.","year":"1996","unstructured":"Petitti DB, Sidney S, Bernstein A, et al. Stroke in users of low-dose oral contraceptives. N Engl J Med 1996;335:8\u201315.","journal-title":"N Engl J Med"},{"key":"ref_13","author":"World Health Statistics Annual 1992","year":"1993","unstructured":"World Health Organization. World Health Statistics Annual 1992. Geneva: World Health Organization, 1993."},{"key":"ref_14","author":"World Health Statistics Annual 1993","year":"1994","unstructured":"World Health Organization. World Health Statistics Annual 1993. Geneva: World Health Organization, 1994."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/01.STR.28.2.280","article-title":"Incidence of stroke and myocardial infarction in women of reproductive age","volume":"28","author":"Petitti, D.B.; Sidney, S.; Quesenberry, C.P.","year":"1997","unstructured":"Petitti DB, Sidney S, Quesenberry CP, et al. Incidence of stroke and myocardial infarction in women of reproductive age. Stroke 1997;28:280\u20133.","journal-title":"Stroke"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with diVering progestagen components","volume":"346","author":"Jick, H.; Jick, S.; Gurewich, V.","year":"1995","unstructured":"Jick H, Jick S, Gurewich V, et al. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with diVering progestagen components. Lancet 1995;346:1589\u201393.","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(96)07496-X","article-title":"Population-based study of risk of venous thromboembolism associated with various oral contraceptives","volume":"349","author":"Farmer, R.D.T.; Lawrenson, R.A.; Thompson, R.G.","year":"1997","unstructured":"Farmer RDT, Lawrenson RA, Thompson RG, et al. Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Lancet 1997;349:83\u20138.","journal-title":"Lancet"},{"key":"ref_18","first-page":"195","article-title":"Oral contraceptives and thrombotic diseases: impact of new epidemiological studies","volume":"54","author":"Lidegaard, \u00d8.; Milsom, I.","year":"1996","unstructured":"Lidegaard \u00d8, Milsom I. Oral contraceptives and thrombotic diseases: impact of new epidemiological studies. Contraception 1996;54:195\u20138.","journal-title":"Contraception"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/oxfordjournals.aje.a116418","article-title":"Fatal stroke and use of oral contraceptives: findings from a case-control study","volume":"136","author":"Thorogood, M.; Mann, J.; Murphy, M.","year":"1992","unstructured":"Thorogood M, Mann J, Murphy M, et al. Fatal stroke and use of oral contraceptives: findings from a case-control study. Am J Epidemiol 1992;136:35\u201345.","journal-title":"Am J Epidemiol"},{"key":"ref_20","first-page":"236","article-title":"Event, incidence and case fatality rates of cerebrovascular disease in","volume":"120","author":"Bonita, R.; Beaglehole, R.; North, J.D.K.","year":"1984","unstructured":"Bonita R, Beaglehole R, North JDK. Event, incidence and case fatality rates of cerebrovascular disease in Auckland, New Zealand. Am J Epidemiol 1984;120:236\u201343.","journal-title":"Auckland, New Zealand. Am J Epidemiol"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"596","DOI":"10.7326\/0003-4819-127-8_Part_1-199710150-00003","article-title":"Use of low-dose oral contraceptives and stroke in young women","volume":"127","author":"Schwartz, S.M.; Siscovick, D.S.; Longstreth, W.T.","year":"1997","unstructured":"Schwartz SM, Siscovick DS, Longstreth WT, et al. Use of low-dose oral contraceptives and stroke in young women. Ann Intern Med 1997;127:596\u2013603.","journal-title":"Ann Intern Med"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/pds.2630020107","article-title":"A concurrent cohort study of oral contraceptive users from the VAMP research bank","volume":"2","author":"Lis, Y.; Spitzer, W.O.; Mann, R.D.","year":"1993","unstructured":"Lis Y, Spitzer WO, Mann RD, et al. A concurrent cohort study of oral contraceptive users from the VAMP research bank. Pharmacoepidemiol Drug Safety 1993;2:51\u201363.","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"346","author":"Bloemenkamp, K.W.M.; Rosendaal, F.R.; Helmerhorst, F.M.","year":"1995","unstructured":"Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, et al. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 1995; 346:1593\u20136.","journal-title":"Lancet"},{"key":"ref_24","first-page":"83","article-title":"Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study","volume":"312","author":"Spitzer, W.O.; Lewis, M.A.; Heinemann, L.A.","year":"1996","unstructured":"Spitzer WO, Lewis MA, Heinemann LA, et al. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ 1996;312:83\u20138.","journal-title":"Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/pds.2630020103","article-title":"Oral contraceptives and cardiovascular disease: an epidemiologic overview","volume":"2","author":"Thorogood, M.","year":"1993","unstructured":"Thorogood M. Oral contraceptives and cardiovascular disease: an epidemiologic overview. Pharmacoepidemiol Drug Safety 1993;2:3\u201316.","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/jama.1996.03530410036030","article-title":"Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients","volume":"275","author":"Normand, S.T.; Glickman, M.E.; RGVRK, Sharma","year":"1996","unstructured":"Normand ST, Glickman ME, Sharma RGVRK, et al. Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients. JAMA 1996;275:1322\u20138.","journal-title":"JAMA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1136\/bmj.315.7114.992","article-title":"Comparison of case-fatality in smokers and non-smokers after acute cardiac event","volume":"315","author":"Sonke, G.S.; Stewart, A.W.; Beaglehole, R.","year":"1997","unstructured":"Sonke GS, Stewart AW, Beaglehole R, et al. Comparison of case-fatality in smokers and non-smokers after acute cardiac event. BMJ 1997;315:992\u20133.","journal-title":"BMJ"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0010-7824(98)00019-5","article-title":"Hormonal contraception and risk of cardiovascular disease: an international perspective","volume":"57","author":"Farley, T.M.M.; Collins, J.; Schlesselman, J.J.","year":"1998","unstructured":"Farley TMM, Collins J, Schlesselman JJ. Hormonal contraception and risk of cardiovascular disease: an international perspective. Contraception 1998;57:211\u221230.","journal-title":"Contraception"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke, J.P.; Koster, T.; Bri\u00ebt, E.","year":"1994","unstructured":"Vandenbroucke JP, Koster T, Bri\u00ebt E, et al. Increased risk of venous thrombosis in oral contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994;344:1453\u20137.","journal-title":"Lancet"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(95)91803-5","article-title":"World distribution of factor V Leiden","volume":"346","author":"Rees, D.C.; Cox, M.; Clegg, J.B.","year":"1995","unstructured":"Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346:1133\u20134.","journal-title":"Lancet"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.1997.03540400055031","article-title":"Ethnic distribution of factor V Leiden in 4047 men and women: Implications for venous thromboembolism screening","volume":"277","author":"Ridker, P.M.; Miletich, J.P.; Hennekens, C.H.","year":"1997","unstructured":"Ridker PM, Miletich JP, Hennekens CH, et al. Ethnic distribution of factor V Leiden in 4047 men and women: Implications for venous thromboembolism screening. JAMA 1997;277:1305\u20137.","journal-title":"JAMA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0140-6736(96)90573-5","article-title":"Leiden and third-generation oral contraceptives","volume":"347","author":"Bloemenkamp, K.W.M.; Rosendaal, F.R.; Helmerhorst, F.M.","year":"1996","unstructured":"Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, et al. Factor V Leiden and third-generation oral contraceptives. Lancet 1996;347:396\u20137.","journal-title":"Lancet"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2141.1997.192707.x","article-title":"Oral contraceptives and venous thrombosis: diVerent sensitivities to activated protein C in women using secondand third-generation oral contraceptives","volume":"97","author":"Rosing, J.; Tans, G.; Nicolaes, G.A.F.","year":"1997","unstructured":"Rosing J, Tans G, Nicolaes GAF, et al. Oral contraceptives and venous thrombosis: diVerent sensitivities to activated protein C in women using secondand third-generation oral contraceptives. Br J Haematol 1997;97:233\u20138.","journal-title":"Br J Haematol"},{"key":"ref_34","first-page":"129","article-title":"for the Transnational Research Group on Oral Contraceptives and the Health of Young Women. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women","volume":"56","author":"Lewis, M.A.; Heinemann, L.A.J.; Spitzer, W.O.","year":"1997","unstructured":"Lewis MA, Heinemann LAJ, Spitzer WO, et al, for the Transnational Research Group on Oral Contraceptives and the Health of Young Women. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women. Contraception 1997;56:129\u201340.","journal-title":"Contraception"},{"key":"ref_35","first-page":"125","article-title":"Oral contraceptive use and the cardiovascular health of Canadian women","volume":"19","author":"Collins, J.A.; Gunby, J.","year":"1997","unstructured":"Collins JA, Gunby J. Oral contraceptive use and the cardiovascular health of Canadian women. J Soc Obstet Gynecol Canada 1997;19:125\u201337.","journal-title":"J Soc Obstet Gynecol Canada"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0010-7824(97)00026-7","article-title":"Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives","volume":"55","author":"Schwingl, P.J.; Shelton, J.","year":"1997","unstructured":"Schwingl PJ, Shelton J. Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives. Contraception 1997;55:125\u20139.","journal-title":"Contraception"}],"container-title":["Journal of Epidemiology and Community Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jech.52.12.775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:42:58Z","timestamp":1759484578000},"score":1,"resource":{"primary":{"URL":"https:\/\/jech.bmj.com\/lookup\/doi\/10.1136\/jech.52.12.775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12]]},"references-count":36,"journal-issue":{"issue":"12","published-online":{"date-parts":[[1998,12,1]]},"published-print":{"date-parts":[[1998,12]]}},"alternative-id":["10.1136\/jech.52.12.775"],"URL":"https:\/\/doi.org\/10.1136\/jech.52.12.775","relation":{},"ISSN":["0143-005X","1470-2738"],"issn-type":[{"value":"0143-005X","type":"print"},{"value":"1470-2738","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,12]]}}}